[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=5eb519e91862c57d8b9c53cd97478fbc7ec391145619832e52daea9852fac7e9",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753289220,
      "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 136075300,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=5eb519e91862c57d8b9c53cd97478fbc7ec391145619832e52daea9852fac7e9"
    }
  },
  {
    "ts": null,
    "headline": "TOP SCIENCE TEACHERS ANNOUNCED FOR 12TH ANNUAL REGENERON STEM TEACHING FELLOWSHIP",
    "summary": "The STEM Leadership Center is excited to announce the teachers selected and school districts represented in Cohort 12 of the Regeneron STEM Teaching Fellowship (2025-26). This competitive award confers a 16-month professional development experience to the following outstanding local science teachers:",
    "url": "https://finnhub.io/api/news?id=1b90521046d02a486cf536cd1a3205ef5c06fed822c70a87d1f9f4dbcca15cbb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753284180,
      "headline": "TOP SCIENCE TEACHERS ANNOUNCED FOR 12TH ANNUAL REGENERON STEM TEACHING FELLOWSHIP",
      "id": 136062754,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The STEM Leadership Center is excited to announce the teachers selected and school districts represented in Cohort 12 of the Regeneron STEM Teaching Fellowship (2025-26). This competitive award confers a 16-month professional development experience to the following outstanding local science teachers:",
      "url": "https://finnhub.io/api/news?id=1b90521046d02a486cf536cd1a3205ef5c06fed822c70a87d1f9f4dbcca15cbb"
    }
  },
  {
    "ts": null,
    "headline": "Atopic Dermatitis Market Forecast Report 2025-2034 | FDA Approval of Tralokinumab-Ldrm Stimulates Treatment Advances",
    "summary": "The atopic dermatitis market, valued at USD 9.33 billion in 2024, is projected to grow at a CAGR of 15.10%, reaching USD 38.07 billion by 2034. Key drivers include increasing prevalence, FDA approvals like LEO Pharma's tralokinumab-ldrm, and novel treatments. Major players include AbbVie, Pfizer, and Regeneron. Atopic Dermatitis Market Atopic Dermatitis Market Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The \"Atopic Dermatitis Market Report and Forecast 2025-2034\" report has been added to ResearchA",
    "url": "https://finnhub.io/api/news?id=9bf7f683fd614ffa47b5eb4949231acd9dc19d386149783b004bef4232492def",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753258080,
      "headline": "Atopic Dermatitis Market Forecast Report 2025-2034 | FDA Approval of Tralokinumab-Ldrm Stimulates Treatment Advances",
      "id": 136039632,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The atopic dermatitis market, valued at USD 9.33 billion in 2024, is projected to grow at a CAGR of 15.10%, reaching USD 38.07 billion by 2034. Key drivers include increasing prevalence, FDA approvals like LEO Pharma's tralokinumab-ldrm, and novel treatments. Major players include AbbVie, Pfizer, and Regeneron. Atopic Dermatitis Market Atopic Dermatitis Market Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The \"Atopic Dermatitis Market Report and Forecast 2025-2034\" report has been added to ResearchA",
      "url": "https://finnhub.io/api/news?id=9bf7f683fd614ffa47b5eb4949231acd9dc19d386149783b004bef4232492def"
    }
  },
  {
    "ts": null,
    "headline": "Longleaf Partners Global Fund Q2 2025 Commentary",
    "summary": "The securities we own all have stock-specific reasons they are undervalued, and some are also driven by a few themes worth calling out before we discuss individual holdings.",
    "url": "https://finnhub.io/api/news?id=851ff9099828858021c05209283180d3744fbb9f72fa7d5d5992786953cbc557",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753254000,
      "headline": "Longleaf Partners Global Fund Q2 2025 Commentary",
      "id": 136040180,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1303046106/image_1303046106.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "The securities we own all have stock-specific reasons they are undervalued, and some are also driven by a few themes worth calling out before we discuss individual holdings.",
      "url": "https://finnhub.io/api/news?id=851ff9099828858021c05209283180d3744fbb9f72fa7d5d5992786953cbc557"
    }
  },
  {
    "ts": null,
    "headline": "Dodge & Cox Global Stock Fund Q2 2025 Shareholder Letter",
    "summary": "Dodge & Cox Global Stock Fund Q2 2025 Shareholder Letter",
    "url": "https://finnhub.io/api/news?id=724fa9435927dec26a63e040818cb1294613f5d6199e74ac4304ad2f7c33dc7d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753246800,
      "headline": "Dodge & Cox Global Stock Fund Q2 2025 Shareholder Letter",
      "id": 136039562,
      "image": "",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=724fa9435927dec26a63e040818cb1294613f5d6199e74ac4304ad2f7c33dc7d"
    }
  }
]